11 research outputs found

    Protection of buried rigid pipes using geogrid-reinforced soil systems subjected to cyclic loading

    Get PDF
    YesThe performance of buried rigid pipes underneath geogrid-reinforced soil while applying incrementally increased cyclic loading was assessed using a fully instrumented laboratory rig. The influence of varying two parameters of practical importance was investigated; the pipe burial depth and the number of geogrid-layers. Measurements were taken for pipe deformation, footing settlement, strain in pipe and reinforcing layers, and pressure/soil stress on the pipe crown during various stages of cyclic loading. The research outcomes demonstrated a rapid increase in the rate of deformation of the pipe and the footing, and the rate of generated strain in the pipe and the geogrid-layers during the first 300 cycles. While applying further cycles, those rates were significantly decreased. Increasing the pipe burial depth and number of geogrid-layers resulted in reductions in the footing and the pipe deformations, the pressure on pipe crown, and the pipe strains. Redistribution of stresses, due to the inclusion of reinforcing layers, formed a confined zone surrounding the pipe providing it with additional lateral support. The pipe invert experienced a rebound, which was found to be dependent on pressure around the pipe and the degree of densification of the bedding layer. Data for strains measured in the geogrid-layers showed that despite the applied loading value and the pipe burial depth, the tensile strain in the lower geogrid-layer was usually higher than that measured in the upper layer

    Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV

    No full text
    Vaccination is the most functional medical intervention to prophylactically control severe diseases caused by human-to-human or animal-to-human transmissible viral pathogens. Annually, seasonal influenza epidemics attack human populations leading to 290−650 thousand deaths/year worldwide. Recently, a novel Middle East Respiratory Syndrome Coronavirus emerged. Together, those two viruses present a significant public health burden in areas where they circulate. Herein, we generated a bacterial outer membrane vesicles (OMVs)-based vaccine presenting the antigenic stable chimeric fusion protein of the H1-type haemagglutinin (HA) of the pandemic influenza A virus (H1N1) strain from 2009 (H1N1pdm09) and the receptor binding domain (RBD) of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) (OMVs-H1/RBD). Our results showed that the chimeric antigen could induce specific neutralizing antibodies against both strains leading to protection of immunized mice against H1N1pdm09 and efficient neutralization of MERS-CoV. This study demonstrate that OMVs-based vaccines presenting viral antigens provide a safe and reliable approach to protect against two different viral infections
    corecore